Novartis Aktie
102,30
EUR
+0,70
EUR
+0,69
%
95,30
CHF
+0,22
CHF
+0,23
%
Werbung
Novartis Aktie Analyse
| 26.04.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 26.04.17 | Novartis Underweight | Morgan Stanley | |
| 26.04.17 | Novartis Hold | Deutsche Bank AG | |
| 25.04.17 | Novartis Hold | S&P Capital IQ | |
| 21.04.17 | Novartis Neutral | UBS AG | |
| 19.04.17 | Novartis Underweight | Morgan Stanley | |
| 18.04.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.17 | Novartis Hold | Deutsche Bank AG | |
|
Werbung
|
|||
| 06.04.17 | Novartis Neutral | UBS AG | |
| 23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.03.17 | Novartis buy | Kepler Cheuvreux | |
| 23.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 23.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.03.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.03.17 | Novartis Hold | Deutsche Bank AG | |
| 15.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 14.03.17 | Novartis Neutral | UBS AG | |
| 10.03.17 | Novartis Hold | Deutsche Bank AG | |
| 09.03.17 | Novartis buy | Jefferies & Company Inc. | |
| 08.03.17 | Novartis Underweight | Barclays Capital | |
| 08.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 07.03.17 | Novartis Underperform | BNP PARIBAS | |
| 17.02.17 | Novartis buy | Jefferies & Company Inc. | |
| 06.02.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.01.17 | Novartis Neutral | UBS AG | |
| 30.01.17 | Novartis buy | HSBC | |
| 26.01.17 | Novartis Underweight | Morgan Stanley | |
| 26.01.17 | Novartis Hold | Deutsche Bank AG | |
| 25.01.17 | Novartis Hold | S&P Capital IQ | |
| 25.01.17 | Novartis Outperform | Bernstein Research | |
| 25.01.17 | Novartis buy | Baader Bank | |
| 24.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 24.01.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 16.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.01.17 | Novartis Hold | Deutsche Bank AG | |
| 03.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.12.16 | Novartis buy | Jefferies & Company Inc. | |
| 13.12.16 | Novartis Hold | Deutsche Bank AG | |
| 13.12.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 13.12.16 | Novartis buy | HSBC | |
| 08.12.16 | Novartis Neutral | UBS AG | |
| 30.11.16 | Novartis Hold | Deutsche Bank AG | |
| 18.11.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 08.11.16 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 31.10.16 | Novartis buy | Baader Wertpapierhandelsbank | |
| 26.10.16 | Novartis Outperform | Credit Suisse Group | |
Werbung
Werbung